Canaccord analyst Kyle Mikson raised the firm’s price target on Exact Sciences to $115 from $92 and keeps a Buy rating on the shares. The firm said we are incrementally bullish on the company’s outlook after a comprehensive investor day and potentially conservative financial targets, which drive our price target increase.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on EXAS:
- Exact Sciences price target raised to $120 from $85 at Stifel
- Exact Sciences price target raised to $106 from $85 at Craig-Hallum
- Exact Sciences price target raised to $110 from $95 at BTIG
- Exact Sciences price target raised to $130 from $100 at Citi
- Exact Sciences price target raised to $120 from $92 at TD Cowen